The FDA’s decision to scrap a little used panel of arthritis experts due to its cost draws criticism from those awaiting new kinds of rheumatology medicines.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fdas-ending-arthritis-panel-disappoints-former-members-2025a1000oab?src=rss
Author :
Publish date : 2025-09-15 07:44:00
Copyright for syndicated content belongs to the linked Source.
